Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. - Wikidata - awgldk - TriplyDB

Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.

Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.

http://www.wikidata.org/entity/Q45383296

about

Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review.Evidence for Resident Memory T Cells in Rasmussen Encephalitis.CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing.Rasmussen encephalitis: Response to early immunotherapy in a case of immune-mediated encephalitis.Rasmussen's encephalitis: A case report Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis.Does brain inflammation mediate pathological outcomes in epilepsy?Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).Intravenous immunoglobulins for epilepsy.Rasmussen's encephalitis: advances in management and patient outcomes.CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders.Shared HLA Class I and II Alleles and Clonally Restricted Public and Private Brain-Infiltrating αβ T Cells in a Cohort of Rasmussen Encephalitis Surgery Patients.A Case Series of Adult-Onset Rasmussen's Encephalitis: Diagnostic and Therapeutic Challenges.Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study.Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.Updates in Refractory Status Epilepticus.Refractory status epilepticus secondary to atypical Rasmussen encephalitis successfully managed with aggressive immunotherapy.Long-term outcome after limited cortical resections in two cases of adult-onset Rasmussen encephalitis

P2860

Q30741122-F141AA85-FDA8-4B24-8A8F-3AAA1EC9EEDC Q30962933-F4731EF2-BB45-4EBD-AAF8-19D33CA71EAD Q34516912-35A7DB40-E7C5-4BF3-8416-FE40EE70697F Q34520675-9CA95BBD-2BCD-4AF8-943A-3D89400E4217 Q35105733-E396DC66-D630-4288-A563-3FC1F46448E3 Q35273202-3038BFFB-FBC8-4690-8656-AF2FD3557C3D Q35863667-74B94CFD-D79F-4447-969A-FD21222724CC Q36901520-CD505278-ABD8-43B7-BF5F-44FE4D363BB9 Q37717421-73826877-E484-403A-8C98-005E3F58C9FA Q38694734-484CAA77-FEED-4730-B28B-2B90E9414EC9 Q38701350-91D92A17-B3A5-4A2D-9B2F-5CA7C2256E5E Q38702121-3E005C92-0343-4A6D-813F-7C8499BCCCE1 Q38789125-4B9E6D20-84A9-45B7-B125-090E818ADF20 Q39032828-3053DFC1-028F-44D9-B524-C8BBAEC80102 Q47112083-6F5E7954-DC22-456F-8E95-769C297D0C85 Q48799486-58AA99F8-15CF-4269-B35D-29F0A8E8AC77 Q52720739-7D29E143-A89A-422A-BB16-090C99A9175A Q54943200-1CA5081F-CC24-4450-98E7-A4725337D0C6 Q55262000-14CA751A-8C88-452D-A33C-E8C5855504C8 Q59204809-4379EFF5-AC04-4521-BF00-0ED268A8459C

P2860

Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.

http://www.wikidata.org/entity/Q45383296

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Rasmussen encephalitis: incide ...... r intravenous immunoglobulins.

@en

Rasmussen encephalitis: incide ...... r intravenous immunoglobulins.

@nl

type

label

Rasmussen encephalitis: incide ...... r intravenous immunoglobulins.

@en

Rasmussen encephalitis: incide ...... r intravenous immunoglobulins.

@nl

prefLabel

Rasmussen encephalitis: incide ...... r intravenous immunoglobulins.

@en

Rasmussen encephalitis: incide ...... r intravenous immunoglobulins.

@nl

P1433

Q45383296-F5262D81-A731-4977-A644-100CF7D042AF

P1476

Q45383296-A6059865-0B0B-4881-B5D1-29955EF46B77

P2093

Q45383296-0545DB28-29E0-4EF9-B724-E5002D97BB32

Q45383296-2B2AAE61-0B91-45EB-986B-C52BFEAD1ED1

Q45383296-36954B89-5BD2-4A45-9D42-E699593E49D1

Q45383296-376617FC-6E6E-4DFF-8660-9C14598ED65F

Q45383296-622AD8B8-8456-43EB-B06D-F2D603C8E47C

Q45383296-62E7F290-0E48-4046-865E-9430AEB0B15A

Q45383296-712DC022-90B8-4511-94E2-EC0655F3D671

Q45383296-9CA6EEDE-3208-443A-98A6-B293B32DE929

Q45383296-B3E6654E-C26B-4469-8874-35B912E554A8

Q45383296-B4EC9CA1-DDB9-465E-BA28-81F6D4042548

P2860

Q45383296-04B1742E-E626-471A-94F7-D9158FEB1ADB

Q45383296-0C1B0F22-0C67-45D7-95A8-A9047ED900F9

Q45383296-0DFCC963-98CD-4CCE-AB26-F160B9D68163

Q45383296-1CDCEFB9-5FC9-41BC-9CB9-AB8C9ADF9EFD

Q45383296-285BDC2A-1A70-4807-9486-DD5572F433D9

Q45383296-38915E47-751E-453A-8F62-7A4903454D53

Q45383296-40BBC45A-8109-41EE-86CE-EB0F2C5A82BE

Q45383296-715DD836-3810-4049-BAF3-A4CC0C545A4E

Q45383296-8C6BD794-684D-40EE-9C02-0A2233820AF9

Q45383296-90F7472A-5093-4538-871A-4D2D9772EDD7

P304

Q45383296-5AE3E846-68F7-4E40-B5FE-8389CB9E1C40

P31

Q45383296-2508E3FD-0960-4F94-A33B-85D8E45E1CB2

P356

Q45383296-75E92930-379C-4D86-B2CF-0CDA8B419C21

P433

Q45383296-24DCC0B7-61B5-43CC-9257-39CC8E3A3B93

P478

Q45383296-F64B1F22-3828-4F10-A136-821C3017A630

P50

Q45383296-53CDB8AC-39EE-44A4-9879-6EE2A440ED56

Q45383296-9247726F-28C4-4597-8691-4C0A3ACFEE28

Q45383296-F6834257-5DC1-42C2-8822-C6D18EBC5B83

P577

Q45383296-1D73C73D-D6B8-4994-A5AA-FBC4AF1363DC

P5875

Q45383296-3709E088-601D-4905-9DEB-0A22632C63B2

P698

Q45383296-6770D84F-0238-45D2-B3B9-4F90282C22F4

P356

P1433

P1476

Rasmussen encephalitis: incide ...... or intravenous immunoglobulins

@en

P2093

Albert J Becker

http://www.w3.org/2001/XMLSchema#string

Bernd Kruse

http://www.w3.org/2001/XMLSchema#string

Bernd Wilken

http://www.w3.org/2001/XMLSchema#string

Christian E Elger

http://www.w3.org/2001/XMLSchema#string

Christian G Bien

http://www.w3.org/2001/XMLSchema#string

Gerhard Kurlemann

http://www.w3.org/2001/XMLSchema#string

Horst Urbach

http://www.w3.org/2001/XMLSchema#string

Michael Karenfort

http://www.w3.org/2001/XMLSchema#string

Peter Herkenrath

http://www.w3.org/2001/XMLSchema#string

Robert Sassen

http://www.w3.org/2001/XMLSchema#string

P2860

Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis.

Functional abilities after stroke: measurement, natural history and prognosis.

Focal seizures due to chronic localized encephalitis.

Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients.

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement.

Why would you remove half a brain? The outcome of 58 children after hemispherectomy-the Johns Hopkins experience: 1968 to 1996.

The Armeo Spring as training tool to improve upper limb functionality in multiple sclerosis: a pilot study

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.

Tacrolimus: a further update of its use in the management of organ transplantation.

P304

543-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EPI.12042

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Henning Tiemeier

Susanne Schubert-Bast

P577

2012-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233874752

http://www.w3.org/2001/XMLSchema#string

P698

23216622

http://www.w3.org/2001/XMLSchema#string